Antagonism of kappa opioid mediated effects in the rat by cyclo (Leu-Gly).
Bhargava
H N
HN
Dept. of Pharmacodynamics, University of Illinois, Chicago 60612.
Ramarao
P
P
D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; D000700:Analgesics / Q000037:antagonists & inhibitors; D000818:Animals; D004232:Diuretics / Q000037:antagonists & inhibitors; D004361:Drug Tolerance; D008297:Male; D009479:Neuropeptides / Q000494:pharmacology*; D010456:Peptides, Cyclic / Q000494:pharmacology*; D011759:Pyrrolidines / Q000037:antagonists & inhibitors; D051381:Rats; D011919:Rats, Inbred Strains; D011957:Receptors, Opioid / Q000187:drug effects* / Q000502:physiology; D017473:Receptors, Opioid, kappa
D000700:Analgesics; D004232:Diuretics; D009479:Neuropeptides; D010456:Peptides, Cyclic; D011759:Pyrrolidines; D011957:Receptors, Opioid; D017473:Receptors, Opioid, kappa; C021166:cyclo(leucylglycine); D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer